Log In
Print
BCIQ
Print
Print this Print this
 

basimglurant (RG7090, RO4917523)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionNegative modulator of metabotropic glutamate receptor subtype 5 (mGluR5; GRM5)
Molecular Target Metabotropic glutamate receptor subtype 5 (mGluR5) (GRM5)
Mechanism of ActionMetabotropic glutamate receptor subtype 5 (mGluR5) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsAdjunctive treatment for major depressive disorder (MDD); Treat treatment-resistant depression
Regulatory Designation

Partner

Chugai Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today